Global Medical Directory is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Connect with this vendor - Learn about this product


•TRUPCR® BCR ABL1 Kit is CE IVD marked according to the Directive 98/79/EC.

• TRUPCR®  BCR ABL1 covers entire molecular workflow solutions and is extensively validated on clinical specimens.

•Detects BCR-ABL1 fusion gene transcripts P210 (e13a2, e14a2), P190 (e1a2), P230 (e19a2) and also differentiate between e13a2 (b2a2) and e14a2 (b3a2) transcript.

•Sensitive to detect up to MR 4.7

•The kit allows highly sensitive deep molecular response reporting based on European Treatment and Outcome Study (EUTOS) guidelines.

•All inclusive kit with complementary software analysis tool and Aligned with certified reference materials.

•Endogenous control gene ABL1 to monitor the quality and quantity of extracted RNA and cDNA control to check the quality of reverse transcription.

•Kit is compatible with QuantStudio® 3, 5 and 12 series, Rotor-Gene Q , Bio-Rad CFX96, CFX384,Roche - LightCycler® 480 -II  and Applied Biosystems™ 7500.

•Easy-to-use, rapid, reliable, comprehensive and cost-effective test.

•The kits are provided as packages of 48 reactions and 96 reactions.